CD28 and neoplasm: Stimulation of Treg cells with anti-CD3 and anti-CD28 coated beads optimized for T cell activation led to a more pronounced increase in IL1R1 expression (up to 50% of blood Treg cells and IL1R1- tumour Treg cells, Extended Data Fig. 7e).